Abstract
Background: After major hepatectomy, postoperative hepatic failure still remains a serious problem. In experimental models, erythropoietin (EPO) and its analogue darbepoetin (DPO) have been shown to improve liver function and liver regeneration. In case of malignant hepatic tumors, the use of EPO is still controversially discussed, suggesting that EPO could stimulate growth of remnant micrometastases leading to early tumor relapse. We therefore studied the influence of DPO-treatment on tumor growth in a model of experimental colorectal liver metastasis. Methods: BALB/c mice received 1×105 syngeneic CT26.WT colorectal cancer cells into the left liver lobe and were randomized into 4 groups: the first group received portalvenous injection (i.p.) of 10μ/kg DPO; the second group received PBS i.p. and served as control; the third group underwent a 50% hepatectomy (Phx) and received PBS i.p.; the fourth group underwent Phx and received 10μ/kg DPO i.p. After 7 days, tumor growth, angiogenesis and leukocyte adhesion were analyzed using intravital fluorescence microscopy. Results: After tumor cell implantation, DPO induced a slight, but not significant increase of tumor volume compared to controls, whereas Phx significantly stimulated tumor growth. Application of DPO after Phx caused an additional stimulation of tumor growth with a significantly increased tumor volume compared to Phx only. DPO also induced tumor angiogenesis and significantly increased microvascular density compared to controls. DPO after Phx also caused an increase of capillary density compared to Phx only. DPO treatment significantly reduced leukocyte adhesion within the tumors as compared to controls. After Phx, leukocyte adhesion within the tumor mass was significantly enhanced, whereas additional DPO treatment again inhibited leukocyte adhesion. Conclusion: Our study indicates that DPO stimulates tumor growth especially after liver resection due to an increase of angiogenesis within the colorectal metastases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Fong Y, Fortner J, Sin RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318
Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J (1999) Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229:210–215
Schmeding M, Boas-Knoop S, Lippert S, Ruehl M, Somasundaram R, Dagdelen T, Neuhaus P, Neumann UP (2008) Erythropoietin promotes hepatic regeneration after extended liver resection in rats. J Gastroenterol Hepatol 23:1125–1131
Lappin TR, Maxwell AP, Johnston PG (2007) Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia. The Oncologist 12:362–365
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Medizin Verlag Heidelberg
About this paper
Cite this paper
Rupertus, K., Corsten, M., Schilling, M.K., Menger, M.D., Kollmar, O. (2009). Darbepoetin promotes tumor growth and angiogenesis of colorectal liver metastases particularly after liver resection. In: Schumpelick, V., Bruch, H.P., Schackert, H.K. (eds) Chirurgisches Forum und DGAV Forum 2009. Deutsche Gesellschaft für Chirurgie, vol 38. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00625-8_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-00625-8_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00624-1
Online ISBN: 978-3-642-00625-8
eBook Packages: Medicine (German Language)